Biomerica, Inc.
BMRA
$3.88
$0.123.19%
NASDAQ
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
|---|---|---|---|---|---|
| Net Income | 39.36% | 36.96% | -16.25% | 20.70% | -16.24% |
| Total Depreciation and Amortization | 5.32% | 9.89% | 5.43% | 16.87% | 9.30% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -78.51% | 82.72% | 213.33% | -66.22% | 485.06% |
| Change in Net Operating Assets | 83.01% | -118.05% | 67.02% | -53.78% | -321.62% |
| Cash from Operations | 41.98% | 6.06% | 19.71% | -8.41% | -4.41% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 75.00% | -450.00% | -- | 100.00% | -- |
| Cash from Investing | 75.00% | -175.00% | -- | -71.43% | -166.67% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 87.58% | -- |
| Cash from Financing | -- | -- | -- | -101.10% | -- |
| Foreign Exchange rate Adjustments | -150.00% | -- | -200.00% | -100.00% | 112.50% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 137.80% | 47.54% | 22.01% | -118.03% | -5.40% |